Workflow
折戟A股、重启港股IPO,中润光能由盈转亏背后的多重隐患
Sou Hu Cai Jing·2025-03-25 12:23

Core Viewpoint - Jiangsu Zhongrun Photovoltaic Technology Co., Ltd. (Zhongrun) is attempting to restart its IPO process in Hong Kong after failing to list in A-shares, facing significant operational challenges and industry-wide issues, including a sharp decline in revenue and a substantial loss in 2024 [3][26]. Group 1: IPO Journey - Zhongrun previously submitted an IPO application to the Shenzhen Stock Exchange in May 2023, aiming to raise 4 billion RMB, with plans to invest in an 8GW high-efficiency photovoltaic cell project and supplement working capital [4][6]. - The company faced scrutiny from the Shenzhen Stock Exchange regarding the rationale behind its fundraising scale and the reasonableness of its working capital needs [5][6]. - After a significant drop in estimated valuation from 428.82-524.11 billion RMB to 200.36-244.88 billion RMB, Zhongrun adjusted its fundraising target from 4 billion RMB to 2.3 billion RMB [6][8]. Group 2: Financial Performance - In 2024, Zhongrun reported a revenue drop of 45.7% year-on-year, with total revenue falling to approximately 11.32 billion RMB, down from 20.84 billion RMB in 2023 [12][17]. - The company's photovoltaic cell revenue plummeted by 51.6% from 189.67 billion RMB in 2023 to 91.79 billion RMB in 2024, while revenue from photovoltaic modules increased slightly [12][17]. - Zhongrun's net loss for 2024 reached 1.36 billion RMB, marking a significant decline from a profit of 1.68 billion RMB in 2023 [17][19]. Group 3: Market Position and Challenges - Zhongrun is the world's largest professional photovoltaic cell manufacturer by shipment volume in 2024, holding an 18.3% market share, and the second-largest overall with a 14.6% market share [12][17]. - The company is experiencing intense competition and price declines in the photovoltaic industry, leading to a significant reduction in average selling prices of its products [14][17]. - The transition from P-type to N-type photovoltaic cells is underway, with N-type sales increasing from 15.9% in 2023 to 54.5% in 2024, reflecting industry trends [17][18]. Group 4: Operational Risks - Zhongrun's inventory surged by 5.21 billion RMB in just one month, raising concerns about liquidity and potential impairment risks due to market fluctuations [22][24]. - The company has a high dependency on a few major customers, with the top five clients accounting for 49.8%, 52.9%, and 37.2% of total revenue over the past three years [20][22]. - The company's financial health is under pressure, with a rising asset-liability ratio from 79.1% in 2022 to 83.7% in 2024, indicating increasing short-term debt challenges [23][24].